-
Reduction of treatment-related toxicities have direct bearing on the decision when to initiate antiretroviral therapy. Clinicians may opt to delay antiretroviral therapy or avoid certain agents because of quality-of-life issues and the risk of treatment-related toxicity.
-
Over the past several years, Japan has been the chief source of measles importation into the United States. A total of 63 cases of measles were imported to the United States from Japan during the past 22 years.
-
This active, population-based, surveillance study was conducted by the CDC, in collaboration with state health departments and universities in 10 states participating in the Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network.
-
It's unpleasant enough to receive a diagnosis of prostate cancer and to face a course of radiotherapy that can cause a number of side effects, ranging from incontinence to a loss of potency.
-
It's great to be armed with scientific evidence, but it does no good if the patients who could benefit from this evidence are not referred to you for care.
-
Powerful new evidence has emerged demonstrating the benefits of radiotherapy in prostate cancer patients following radical prostatectomy.
-
The Food and Drug Administration (FDA) has sent an alert about X-rays used during CT examinations that might cause implanted and external electronic medical devices to malfunction.
-
In the next few months, researchers at the University of California at Los Angeles' (UCLA's) Jonsson Comprehensive Cancer Center will begin human studies on a new probe for Positron Emission Tomography (PET) that they believe will provide clinicians and researchers with a powerful new window on the immune system, as well as enable them to gauge early patient response to therapies.
-
Could whole milk work just as well as the more expensive, barium-based contrast agents for imaging of the gastrointestinal tract?
-
In the absence of any randomized clinical trial data, clinicians aren't exactly sure when it makes good sense to order magnetic resonance imaging (MRI) prior to breast cancer surgery and when it is more likely to offer little benefit.